Tovecimig is a G1-scFv-based monoclonal antibody that specifically targets both vascular endothelial growth factor A (VEGFA) and Delta-like ligand 4 (DLL4), two key regulators of angiogenesis. By simultaneously inhibiting VEGFA and DLL4 signaling, Tovecimig offers a dual anti-angiogenic mechanism that may support research into tumor vascularization, resistance to anti-VEGF therapies, and other angiogenesis-dependent pathologies.
Tovecimig is a G1-scFv-based monoclonal antibody that specifically targets both vascular endothelial growth factor A (VEGFA) and Delta-like ligand 4 (DLL4), two key regulators of angiogenesis. By simultaneously inhibiting VEGFA and DLL4 signaling, Tovecimig offers a dual anti-angiogenic mechanism that may support research into tumor vascularization, resistance to anti-VEGF therapies, and other angiogenesis-dependent pathologies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
